{"denoms":[{"counts":[{"groupId":"BG000","value":"21"}],"units":"Participants"}],"groups":[{"description":"Dasatinib will be administered continuously at an oral dose of 70 mg BID on Days 1-28 of each 28 day cycle.","id":"BG000","title":"Dasatinib"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"38","upperLimit":"76","value":"59"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"14"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Stage IA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Stage IIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}]}],"title":"Stage IIIA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Stage IIIB"}],"description":"Stage I: Hemoglobin (Hb) \\> 10g/dL, normal calcium, normal or single plasmacytoma or osteoporosis, Serum paraprotein level \\< 5 g/dL if IgG, \\< 3 g/dL if IgA, Urinary light chain excretion \\< 4 g/24h Stage 2: Not fufilling criteria of Stage I or III Stage III: Hb \\< 8.5g/dL, calcium \\> 12 mg/dL, 3 or more lytic bone lesions, Serum paraprotein \\> 7g/dL if IgG, \\> 5 g/dL if IgA, Urinary light chain excretion \\> 12g/24h\n\nStages I, II, and III can be divided into A or B depending on serum creatinine:\n\nA: serum creatinine \\< 2 mg/dL (\\< 177 μmol/L) B: serum creatinine \\> 2 mg/dL (\\> 177 μmol/L)","paramType":"NUMBER","title":"Durie-Salmon Stage","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"1","upperLimit":"14","value":"3"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Prior therapies","unitOfMeasure":"therapies"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"19"}]}],"title":"Immunomodulatory agents"},{"categories":[{"measurements":[{"groupId":"BG000","value":"10"}]}],"title":"Bortezomib"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"Anthracycline-containing regimens"},{"categories":[{"measurements":[{"groupId":"BG000","value":"19"}]}],"title":"Prior autologous stem cell transplant"}],"paramType":"NUMBER","title":"Prior therapies","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"1.2","upperLimit":"13","value":"2.7"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Beta 2 microglobulin at study entry","unitOfMeasure":"mg/L"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"Relapsed"},{"categories":[{"measurements":[{"groupId":"BG000","value":"7"}]}],"title":"Plateau phase"}],"paramType":"NUMBER","title":"Disease status at study entry","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"IgG"},{"categories":[{"measurements":[{"groupId":"BG000","value":"6"}]}],"title":"IgA"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Light chain only"}],"paramType":"NUMBER","title":"Paraprotein","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"Normal"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Del 13/13q"},{"categories":[{"measurements":[{"groupId":"BG000","value":"2"}]}],"title":"Complex (including 1 with t4;14)"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"t9;16"},{"categories":[{"measurements":[{"groupId":"BG000","value":"1"}]}],"title":"Del 6p"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Unavailable"}],"paramType":"NUMBER","title":"Cytogenetics","unitOfMeasure":"participants"}]}